Merck, the top US pharmaceutical company, said yesterday its fourth-quarter profits rose 12 per cent, in line with Wall Street expectations, on strong sales of established and newer medicines. Merck, which has significant operations in Co Tipperary, said profits climbed to $1.57 billion (€1.57 billion) from $1.4 billion in the year-ago quarter.